Flow Cytometry Market to Surpass US$ 9.3 Billion Globally by end of 2027 - Coherent Market Insights

News provided by

Mar 26, 2020, 11:32 ET

SEATTLE, March 26, 2020 /PRNewswire/ -- According to Coherent Market Insights, the global flow cytometry market was valued at US$ 3,886.1 million in 2018 and is expected to exhibit a CAGR of 10.2% over the forecast period (2019-2027).

Key Trends and Analysis of the Flow Cytometry Market:

Key trends in market include rising patient pool in the HIV, autoimmune disorders, cancers such as leukemia, lymphoma or myeloma, technological advancements of the products in the market, and adoption of inorganic growth strategies such as acquisitions, agreements, mergers & collaborations by the market players, which are expected to boost growth of the flow cytometry market over the forecast period.

Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/1152

The increasing number of patients with autoimmune disorders is expected to propel the market growth during the forecast period. For instance, according to the American Autoimmune Related Diseases Association (AARDA), the article published in December 2018 states that there are over 100 known autoimmune diseases, which include psoriasis, Graves' disease, Sjogren's syndrome, type 1 diabetes, relapsing polychondritis, myasthenia gravis, multiple sclerosis, rheumatoid arthritis, Crohn's disease, lupus, and others. The article also reports that around 50 million U.S. population are suffering with autoimmune disorders and among them 75.0% are women.

Major players are focusing on acquisitions to strengthen their position in the flow cytometry market. For instance, in 2018, Agilent Technologies, Inc. entered into an agreement to acquire ACEA Biosciences Inc. This strategy was aimed to expand its global revenue base, product portfolio, and strengthen its market share. Moreover, in September 2015, BD Life Sciences entered into a collaborative agreement with Seegene Inc. for the development of multiplex real-time PCR reagents for the BD max system in a probe to gain competitive advantage.

Key Market Takeaways:

The global flow cytometry market is expected to exhibit a CAGR of 10.2% during the forecast period (2019-2027), which is attributed to rising cases of HIV/AIDS. For instance, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS), in 2015, around 36.7 million people globally were infected with HIV and among them 1.8 million people were under the age of 15.
Key players in the market are focusing on launching technologically advanced products to make the market well enhanced and featured digitally to enhance their product portfolio, which is expected to propel the market growth over the forecast period. For instance, in September 2017, Miltenyi Biotec GmbH (Germany) launched a fully automated high-throughput flow cytometry MACSQuant X, which handles 384-well plates in less than 60 minutes providing users fast, reliable, and reproducible results. Moreover, launch of the product expanded the flow cytometry product line of company.

Key players operating in the global flow cytometry market include—

Becton Dickinson and Company, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Merck & Co Inc., Sysmex Corporation, Agilent Technologies, Inc., and Danaher Corporation.

Buy this Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/1152

Market Segmentations:

Global Flow Cytometry market, By Technology:

Cell-Based
Bead-Based

Global Flow Cytometry market, By Product Type:

Analyzer
Sorter
Reagents & Consumables

Global Flow Cytometry market, By Application:

Research
Clinical
Industrial

Global Flow Cytometry market, By End User:

Hospital
Clinical Testing Laboratories
Research laboratories

Global Flow Cytometry market, By Region:

North America

By Country:

U.S.
Canada

Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

Europe

By Country:

U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe

Asia Pacific

By Country:

China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific

Middle East

By Country:

GCC
Israel
Rest of Middle East

Africa

By Country/Region:

North Africa
Central Africa
South Africa

Did not find what you were looking for? Here are some similar Topics:

VIRAL VECTOR AND PLASMID DNA TESTING SERVICES MARKET

Viral vectors are the best approach used in the gene therapies and therefore, testing services are the key factors for the timely development of viral vector-based therapies. Viral vector characterization plays an important role for orthogonal analytical approaches. The characterization is significant through the regulatory perspective, which include product safety, identity, purity, and potency.

GMP CELL BANKING SERVICES MARKET

GMP cell banking services is termed as the storing of cells of specific genome for the purpose of future use in a product or medicinal needs. Different types of cell lines stored in cell banks constitute of mammalian cells, microbial cells, insect cell lines, yeast cells, avian cells, and stem cells. Increasing funding for R&D in rare diseases is expected to boost growth of the global GMP cell banking services market over the forecast period.

DNA AND RNA SAMPLE PREPARATION MARKET

DNA and RNA samples are necessary for variety of applications in drug research and development and cancer studies. High quality DNA and RNA samples are important for a wide variety of research and clinical applications. Biological studies require purified and isolated nucleic acids as the first step and in all recombinant DNA techniques. The extraction of nucleic acids from biological material requires cell lysis, inactivation of cellular nucleases, and separation of the desired nucleic acid from cellular debris.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email-[email protected]

SOURCE Coherent Market Insights